Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications

Abstract Hepatocellular carcinoma features extensive metabolic reprogramming. This includes alterations in major biochemical pathways such as glycolysis, the pentose phosphate pathway, amino acid metabolism and fatty acid metabolism. Moreover, there is a complex interplay among these altered pathway...

Full description

Saved in:
Bibliographic Details
Main Authors: Sujin Park, Michael N. Hall
Format: Article
Language:English
Published: Nature Publishing Group 2025-03-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-025-01415-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850268665704873984
author Sujin Park
Michael N. Hall
author_facet Sujin Park
Michael N. Hall
author_sort Sujin Park
collection DOAJ
description Abstract Hepatocellular carcinoma features extensive metabolic reprogramming. This includes alterations in major biochemical pathways such as glycolysis, the pentose phosphate pathway, amino acid metabolism and fatty acid metabolism. Moreover, there is a complex interplay among these altered pathways, particularly involving acetyl-CoA (coenzyme-A) metabolism and redox homeostasis, which in turn influences reprogramming of other metabolic pathways. Understanding these metabolic changes and their interactions with cellular signaling pathways offers potential strategies for the targeted treatment of hepatocellular carcinoma and improved patient outcomes. This review explores the specific metabolic alterations observed in hepatocellular carcinoma and highlights their roles in the progression of the disease.
format Article
id doaj-art-03baef2aba2346e79a85400aec87a5f3
institution OA Journals
issn 2092-6413
language English
publishDate 2025-03-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj-art-03baef2aba2346e79a85400aec87a5f32025-08-20T01:53:23ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132025-03-0157351552310.1038/s12276-025-01415-2Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implicationsSujin Park0Michael N. Hall1Center for Genome Engineering, Institute for Basic ScienceBiozentrum, University of BaselAbstract Hepatocellular carcinoma features extensive metabolic reprogramming. This includes alterations in major biochemical pathways such as glycolysis, the pentose phosphate pathway, amino acid metabolism and fatty acid metabolism. Moreover, there is a complex interplay among these altered pathways, particularly involving acetyl-CoA (coenzyme-A) metabolism and redox homeostasis, which in turn influences reprogramming of other metabolic pathways. Understanding these metabolic changes and their interactions with cellular signaling pathways offers potential strategies for the targeted treatment of hepatocellular carcinoma and improved patient outcomes. This review explores the specific metabolic alterations observed in hepatocellular carcinoma and highlights their roles in the progression of the disease.https://doi.org/10.1038/s12276-025-01415-2
spellingShingle Sujin Park
Michael N. Hall
Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
Experimental and Molecular Medicine
title Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
title_full Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
title_fullStr Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
title_full_unstemmed Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
title_short Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
title_sort metabolic reprogramming in hepatocellular carcinoma mechanisms and therapeutic implications
url https://doi.org/10.1038/s12276-025-01415-2
work_keys_str_mv AT sujinpark metabolicreprogramminginhepatocellularcarcinomamechanismsandtherapeuticimplications
AT michaelnhall metabolicreprogramminginhepatocellularcarcinomamechanismsandtherapeuticimplications